Serum soluble CD23 but not IL8, IL10, GM-CSF, or IFN-γ is elevated in patients with hepatitis C infection

Clinical Immunology and Immunopathology

Volumn 84, Issue 2, 1997, Pages 139-144

  Bansal, A S ^a   Bruce, J ^a   Hogan, P G ^a   Prichard, P ^a   Powell, E E ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CD23 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 8;

ADULT; ALCOHOL LIVER CIRRHOSIS; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; B CELL LYMPHOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETIOLOGY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; VIRUS DIAGNOSIS; VIRUS HEPATITIS;

EID: 0031214279     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4371     Document Type: Article

References (36)

1. Meyer-zum-Buschenfelde K. H., Lohse A. W., Gerken G., Treichel U., Lohr H. F., Mohr H., Grosse A., Dienes H. P. The role of autoimmunity in hepatitis C infection. J. Hepatol. 22:1995;93-96.
2. Clifford B. D., Donahue D., Smith L., Cable E., Luttig B., Manns M., Bonkovsky H. L. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology. 21:1995;613-619.
3. Preziati D., La-Rosa L., Covini G., Marcelli R., Rescalli S., Persani L., Del-Ninno E., Meroni P. L., Colombo M., Beck-Peccoz P. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur. J. Endocrinol. 132:1995;587-593.
4. Ferri C., Baicchi U., la-Civita L., Greco F., Longombardo G., Mazzoni A., Careccia G., Bombardieri S., Pasero G., Zignego A. L. Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda. Eur. J. Clin. Invest. 23:1993;851-855.
5. Carella C., Amato G., Biondi B., Rotondi M., Morisco F., Tuccillo C., Chiuchiolo N., Signoriello G., Caporaso N., Lombardi G. Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis. Horm. Res. 44:1995;110-114.
6. Mazzaro C., Tulissi P., Moretti M., Mazzoran L., Pussini E., Crovatto M., Santini G. F., Pozzato G. Clinical and virological findings in mixed cryoglobulinaemia. J. Intern. Med. 238:1995;153-160.
7. Wong V. S., Egner W., Elsey T., Brown D., Alexander G. J. Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection. Clin. Exp. Immunol. 104:1996;25-31.
8. Ferri C., Longombardo G., La Civita L., Greco F., Lombardini F., Cecchetti R., Cagianelli M. A., Marchi S., Monti M., Zignego A. L. Hepatitis C virus chronic infection as a common cause of mixed cryoglobulinaemia and autoimmune liver disease. J. Intern. Med. 236:1994;31-36.
9. Silvestri F., Pipan C., Barillari G., Zaja F., Fanin R., Infanti L., Russo D., Falasca E., Botta G. A., Baccarani M. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood. 87:1996;4296-4301.
10. Ferri C., Caracciolo F., Zignego A. L., La-Civita L., Monti M., Longombardo G., Lombardini F., Greco F., Capochiani E., Mazzoni A. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br. J. Haematol. 88:1994;392-394.
11. Luppi M., Grazia-Ferrari M., Bonaccorsi G., Longo G., Narni F., Barozzi P., Marasca R., Mussini C., Torelli G. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. Leukemia. 10:1996;351-355.
12. Delespesse G., Suter U., Mossalayi D., Bettler B., Sarfatio M., Sarfati M., Hofstetter H., Kilcherre E., Debre P., Dalloul A. A. Expression, structure and function of the CD23 antigen. Adv. Immunol. 49:1991;149-191.
13. Gordon J. CD23 and B cell activation. Clin. Exp. Allergy. 22:1992;199-204.
14. Bansal A. S., Roberts T., Hay E. M., Kay R., Pumphrey R. S. H., Wilson P. B. Soluble CD23 levels are elevated in the serum of patients with primary Sjögrens syndrome and SLE. Clin. Exp. Immunol. 89:1992;452-455.
15. Bansal A. S., Ollier W., Marsh M. N., Pumphrey R. S. H., Wilson P. B. Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity. Immunology. 79:1993;285-289.
16. Bansal A. S., Cochrane S., Haeney M. R., Bhavnani M., Pumphrey R. S. H., Wilson P. B. Serum soluble CD23 in conditions with hypogammaglobulinaemia and varying B cell numbers. Clin. Exp. Immunol. 97:1994;239-241.
17. Vinante F., Vassanelli A., Zanotti R., Nadali G., Krampera M., Vincenzi C., Morosato L., Chilosi M., Pizzolo G. Circulating levels of soluble CD23 reflect clinical and biological features of leukeamic B-cell chronic lymphoproliferative disorders. Int. J. Clin. Lab. Res. 25:1995;189-194.
18. Torre D., Zeroli C., Giola M., Ferrario G., Fiori G. P., Bonetta G., Tambini R. Serum levels of interleukin-1 alpha, interleukin-1 beta, interleukin-6 and tumour necrosis factor in patients with acute viral hepatitis. Clin. Exp. Dis. 18:1994;194-198.
19. Scheuer P. Classification of chronic viral hepatitis: A need for reassessment. J. Hepatol. 13:1991;372-374.
20. Mossalayi M. D., Dalloul A. H., Fourcade C., Arcock M., Merle-Beral H., Hoffstetter H., Debre P. The role of CD23 on early human haematopoietic precursors. Monogr. Allergy. 29:1991;178-185.
21. Bansal A. S., MacGregor A. J., Pumphrey R. S. H., Ollier W. E. R., Silman A. J., Wilson P. B. Increased levels of sCD23 in rheumatoid arthritis are related to disease status. Clin. Exp. Rheumatol. 12:1994;281-285.
22. Zufferey P., Meyer O. C., Grossin M., Kahn M. F. Primary Sjogren's syndrome (SS) and malignant lymphoma: A retrospective cohort study of 55 patients with SS. Scand. J. Rheumatol. 24:1995;342-345.
23. Tzioufas A. G., Boumba D. S., Skopouli F. N., Moutsopoulos H. M. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjogren's syndrome. Arthritis Rheuma. 39:1996;767-772.
24. Al-Janadi M., Al-Wabel A., Raziuddin S. Soluble CD23 and interleukin-4 levels in autoimmune chronic active hepatitis and systemic lupus erythematosus. Clin. Immunol. Immunopathol. 71:1994;33-37.
25. Ling P. D., Hsieh J. J., Ruf I. K., Rawlins D. R., Hayward S. D. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targetting intermediate, CBF1. J. Virol. 68:1994;5375-5383.
26. Wang F., Kikutani H., Tsang S. F., Kishomoto T., Kieff E. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element. J. Virol. 65:1991;4101-4106.
27. Kamel O. W., van de Rijn M., Hanasono M. M., Warnke R. A. Immunosuppression associated lymphoproliferative disorders in rheumatic patients. Leuk. Lymphoma. 16:1995;363-368.
28. Haddad J., Deny P., Munz-Gotheil C., Ambrosini J. C., Trinchet J. C., Pateron D., Mal F., Callard P., Beaugrand M. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C liver disease. Lancet. 339:1992;321-323.
29. Durand J. M., Lefevre P., Kaplanski G., Retornaz F., Cretel E., Chaussegros C., Trepo C., Soubeyrand J. Sjögren's syndrome and hepatitis C virus infection. Clin. Rheumatol. 14:1995;570-571.
30. Vaughan J. H., Nguyen M. D., Valbracht J. R., Patrick K., Rhodes G. H. Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes: Presence in autoimmune disease. J. Clin. Invest. 95:1995;1316-1327.
31. Baboonian C., Venables P. J., Williams D. G., Williams R. O., Maini R. N. Cross reaction of antibodies to a glycine/alanine repeat sequence of Epstein-Barr virus nuclear antigen-1 with collagen, cytokeratin, and actin. Ann. Rheum. Dis. 50:1991;772-775.
32. Hummel M., Anagnostopoulos I., Korbjuhn P., Stein H. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: Unexpected infection patterns and different infection incidence in low and high grade types. J. Pathol. 175:1995;263-271.
33. Liu Y. J., Mason D. Y., Johnson G. D., Abbot S., Gregory C. D., Hardie D. L., Gordon J., MacLennan I. C. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur. J. Immunol. 21:1991;1905-1910.
34. Bonnefoy J. Y., Henchoz S., Hardie D., Holder M. J., Gordon J. A subset of anti-CD21 antibodies promote the rescue of germinal center B cells from apoptosis. Eur. J. Immunol. 23:1993;969-972.
35. Ellis M., Rathaus M., Amiel A., Manor Y., Klein A., Lishner M. Monoclonal lymphocyte proliferation and bcl-2 rearrangement in essential mixed cryoglobulinaemia. Eur. J. Clin. Invest. 25:1995;833-837.
36. Yawetz S., Cumberland W. G., van der Meyden M., Martinez-Maza O. Elevated serum levels of soluble CD23 (sCD23) precede the appearance of acquired immunodeficiency syndrome-associated non-Hodgkin's lymphoma. Blood. 85:1995;1843-1849.